{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:56:34Z","timestamp":1792086994793,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Continuous positive airway pressure (CPAP) treatment results in nearly complete remission of symptoms of obstructive sleep apnoea (OSA); however, its effect on OSA comorbidities including cardiovascular diseases remains contradictory. Here we investigated the short- and long-term effect of CPAP treatment on matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in patients with severe OSA. Serum levels of 7 MMPs and 3 TIMPs were followed in OSA patients (n\u2009=\u200928) with an apnoea-hypopnoea index of \u226530 events\/h at the time of diagnosis and at control visits (2 months, 6 months and 5 years) after initiation of fixed-pressure CPAP treatment. The first few months of CPAP therapy resulted in significant decrease of MMP-8 and MMP-9 levels (MMP-8: 146 (79\u2013237) vs. 287 (170\u2013560) pg\/mL; MMP-9: 10.1 (7.1\u201314.1) vs. 12.7 (10.4\u201315.6) ng\/mL, p\u2009&lt;\u20090.05 for each at 2 months), while the rest of the panel remained unchanged as compared to baseline values. In contrast, at 5 years, despite of uninterrupted CPAP treatment and excellent adherence the levels of MMP-8, MMP-9 and TIMPs significantly increased (p\u2009&lt;\u20090.05). Our data suggest that initiation of CPAP therapy leads to a decrease in the level of key MMPs in the short-term; however, this effect is not sustained over the long-term.<\/jats:p>","DOI":"10.1038\/s41598-020-65029-6","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T10:02:44Z","timestamp":1590400964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of 5-year continuous positive airway pressure treatment on MMPs and TIMPs: implications for OSA comorbidities"],"prefix":"10.1038","volume":"10","author":[{"given":"Beatrix","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Barta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Gabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Paska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Boszormenyi Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Vizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Antus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"key":"65029_CR1","doi-asserted-by":"publisher","first-page":"608438","DOI":"10.1155\/2015\/608438","volume":"2015","author":"HJ Eisele","year":"2015","unstructured":"Eisele, H. J., Markart, P. & Schulz, R. Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxid. Med. Cell. Longev. 2015, 608438, https:\/\/doi.org\/10.1155\/2015\/608438 (2015).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"65029_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(08)61622-0","volume":"373","author":"TD Bradley","year":"2009","unstructured":"Bradley, T. D. & Floras, J. S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373, 82\u201393, https:\/\/doi.org\/10.1016\/S0140-6736(08)61622-0 (2009).","journal-title":"Lancet"},{"key":"65029_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejphar.2017.09.007","volume":"816","author":"JL Johnson","year":"2017","unstructured":"Johnson, J. L. Metalloproteinases in atherosclerosis. Eur. J. Pharmacol 816, 93\u2013106, https:\/\/doi.org\/10.1016\/j.ejphar.2017.09.007 (2017).","journal-title":"Eur. J. Pharmacol"},{"key":"65029_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.yjmcc.2018.08.026","volume":"123","author":"VA Myasoedova","year":"2018","unstructured":"Myasoedova, V. A., Chistiakov, D. A., Grechko, A. V. & Orekhov, A. N. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling. J. Mol. Cell. Cardiol. 123, 159\u2013167, https:\/\/doi.org\/10.1016\/j.yjmcc.2018.08.026 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"65029_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2013.11.040","volume":"232","author":"CH Tan","year":"2014","unstructured":"Tan, C. H. et al. Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness. Atherosclerosis 232, 199\u2013203, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.040 (2014).","journal-title":"Atherosclerosis"},{"key":"65029_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3988\/jcn.2011.7.2.69","volume":"7","author":"SH Heo","year":"2011","unstructured":"Heo, S. H. et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J. Clin. Neurol. 7, 69\u201376, https:\/\/doi.org\/10.3988\/jcn.2011.7.2.69 (2011).","journal-title":"J. Clin. Neurol."},{"key":"65029_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","volume":"107","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg, S. et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107, 1579\u20131585, https:\/\/doi.org\/10.1161\/01.CIR.0000058700.41738.12 (2003).","journal-title":"Circulation"},{"key":"65029_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1183\/09031936.00146510","volume":"38","author":"S L\u00f6ffek","year":"2011","unstructured":"L\u00f6ffek, S., Schilling, O. & Franzke, C. W. Series \u201cmatrix metalloproteinases in lung health and disease\u201d: Biological role of matrix metalloproteinases: a critical balance. Biological role of matrix metalloproteinases: a critical balance. Eur. Resp. J. 38, 191\u2013208, https:\/\/doi.org\/10.1183\/09031936.00146510 (2011).","journal-title":"Eur. Resp. J."},{"key":"65029_CR9","doi-asserted-by":"publisher","first-page":"E362","DOI":"10.25011\/cim.v38i6.26199","volume":"38","author":"E Hopps","year":"2015","unstructured":"Hopps, E. & Caimi, G. Obstructive sleep apnea syndrome: links between pathophysiology and cardiovascular complications. Clin. Invest. Med 38, E362\u2013E370, https:\/\/doi.org\/10.25011\/cim.v38i6.26199 (2015).","journal-title":"Clin. Invest. Med"},{"key":"65029_CR10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/00029330-200709010-00003","volume":"120","author":"J Ye","year":"2007","unstructured":"Ye, J., Liu, H., Li, Y., Liu, X. & Zhu, J. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin. Med. J. 120, 1482\u20131486, https:\/\/doi.org\/10.1097\/00029330-200709010-00003 (2007).","journal-title":"Chin. Med. J."},{"key":"65029_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.lfs.2013.06.009","volume":"93","author":"LP Chuang","year":"2013","unstructured":"Chuang, L. P. et al. Increased matrix metalloproteinases-9 after sleep in plasma and in monocytes of obstructive sleep apnea patients. Life. Sci. 93, 220\u2013225, https:\/\/doi.org\/10.1016\/j.lfs.2013.06.009 (2013).","journal-title":"Life. Sci."},{"key":"65029_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5152\/balkanmedj.2012.068","volume":"30","author":"M Y\u00fcksel","year":"2013","unstructured":"Y\u00fcksel, M., Kuzu-Okur, H., Velio\u011flu-\u00d6\u011f\u00fcn\u00e7, A. & Pelin, Z. Matrix metalloproteinase-9 level and gene polymorphism in sleep disordered breathing patients with or without cardiovascular disorders. Balkan. Med. J 30, 8\u201312, https:\/\/doi.org\/10.5152\/balkanmedj.2012.068 (2013).","journal-title":"Balkan. Med. J"},{"key":"65029_CR13","doi-asserted-by":"publisher","first-page":"1569701","DOI":"10.1155\/2018\/1569701","volume":"2018","author":"S Wang","year":"2018","unstructured":"Wang, S., Li, S., Wang, B., Liu, J. & Tang, Q. Matrix metalloproteinase-9 is a predictive factor for systematic hypertension and heart dysfunction in patients with obstructive sleep apnea syndrome. Biomed. Res. Int. 2018, 1569701, https:\/\/doi.org\/10.1155\/2018\/1569701 (2018).","journal-title":"Biomed. Res. Int."},{"key":"65029_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.sleep.2007.10.011","volume":"10","author":"K Christou","year":"2009","unstructured":"Christou, K. et al. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med. 10, 87\u201394, https:\/\/doi.org\/10.1016\/j.sleep.2007.10.011 (2009).","journal-title":"Sleep Med."},{"key":"65029_CR15","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1164\/rccm.200402-193OC","volume":"170","author":"T Tazaki","year":"2004","unstructured":"Tazaki, T. et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 170, 1354\u20131359, https:\/\/doi.org\/10.1164\/rccm.200402-193OC (2004).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"65029_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ppul.21251","volume":"45","author":"AG Kaditis","year":"2010","unstructured":"Kaditis, A. G. et al. Adiposity and low-grade systemic inflammation modulate matrix metalloproteinase-9 levels in Greek children with sleep apnea. Pediatr. Pulmonol. 45, 693\u2013699, https:\/\/doi.org\/10.1002\/ppul.21251 (2010).","journal-title":"Pediatr. Pulmonol."},{"key":"65029_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2017.7967","volume":"318","author":"J Yu","year":"2017","unstructured":"Yu, J. et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA 318, 156\u2013166, https:\/\/doi.org\/10.1001\/jama.2017.7967 (2017).","journal-title":"JAMA"},{"issue":"5","key":"65029_CR18","doi-asserted-by":"publisher","first-page":"1702400","DOI":"10.1183\/13993003.02400-2017","volume":"51","author":"Miguel Angel Martinez-Garcia","year":"2018","unstructured":"Martinez-Garcia, M. A., Campos-Rodriguez, F., Javaheri, S. & Gozal, D. Pro: continuous positive airway pressure and cardiovascular prevention. Eur. Respir. J. 51, pii: 1702400, https:\/\/doi.org\/10.1183\/13993003.02400-2017 (2018).","journal-title":"European Respiratory Journal"},{"issue":"5","key":"65029_CR19","doi-asserted-by":"publisher","first-page":"1702721","DOI":"10.1183\/13993003.02721-2017","volume":"51","author":"R. Doug McEvoy","year":"2018","unstructured":"McEvoy, R.D. & Kohler, M. Con: continuous positive airway pressure and cardiovascular prevention. Eur. Respir. J. 51, pii: 1702721, https:\/\/doi.org\/10.1183\/13993003.02721-2017 (2018).","journal-title":"European Respiratory Journal"},{"key":"65029_CR20","doi-asserted-by":"publisher","unstructured":"Bikov, A. et al. Comprehensive coronary plaque assessment in patients with obstructive sleep apnea. J. Sleep. Res., e12828. https:\/\/doi.org\/10.1111\/jsr.12828 (2019).","DOI":"10.1111\/jsr.12828"},{"key":"65029_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.smrv.2019.03.010","volume":"46","author":"A Franczak","year":"2019","unstructured":"Franczak, A. et al. Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity - A systematic review. Sleep Med. Rev. 46, 9\u201316, https:\/\/doi.org\/10.1016\/j.smrv.2019.03.010 (2019).","journal-title":"Sleep Med. Rev."},{"key":"65029_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2006.09.011","volume":"191","author":"CK Roberts","year":"2007","unstructured":"Roberts, C. K., Chen, A. K. & Barnard, R. J. Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 191, 98\u2013106, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.09.011 (2007).","journal-title":"Atherosclerosis"},{"issue":"2","key":"65029_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/cells8020158","volume":"8","author":"Gabriela Berg","year":"2019","unstructured":"Berg, G., Barchuk, M. & Miksztowicz, V. Behavior of metalloproteinases in adipose tissue, liver and arterial wall: an update of extracellular matrix remodeling. Cells 8, pii: E158, https:\/\/doi.org\/10.3390\/cells8020158 (2019).","journal-title":"Cells"},{"key":"65029_CR24","doi-asserted-by":"publisher","unstructured":"Simon, B. et al. Effect of 5-year continuous positive airway pressure treatment on the lipid profile of patients with obstructive sleep apnea: a pilot study. J. Sleep. Res. e12874, https:\/\/doi.org\/10.1111\/jsr.12874 (2019).","DOI":"10.1111\/jsr.12874"},{"key":"65029_CR25","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1164\/rccm.201003-0451OC","volume":"182","author":"B Antus","year":"2010","unstructured":"Antus, B. et al. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: a longitudinal study. Am. J. Respir. Crit. Care Med. 182, 1492\u20131497, https:\/\/doi.org\/10.1164\/rccm.201003-0451OC (2010).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65029-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65029-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:01:47Z","timestamp":1670328107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65029-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65029"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65029-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8609"}}